GlobalIPNews

Sign Up
|
Login
|

06:44:39 Thu 18 Jun 2026

Home
About Us
Industry
Assignee
Country
Support
Products
Services
View ALl

News For Last 1 Week

Industry

X

Assignee

X

Shanghai Jiao Tong Univer

(38)

Tianjin University

(31)

Hoffmann La Roche

(22)

Gilead Sciences

(14)

Chia Tai Tianqing Pharmac

(11)

Jiangsu Hengrui Pharmaceu

(11)

Eli Lilly and Company

(10)

(10)

(9)

Beijing Sun Novo Pharmace

(9)

Regeneron Pharmaceuticals

(9)

Tianjin University of Sci

(9)

(8)

Haisco Pharmaceutical Gro

(8)

(8)

Shanghai Hansoh Biomedica

(8)

Shenzhen Salubris Pharmac

(8)

Shanghai Qilu Pharmaceuti

(7)

Chugai Pharmaceutical

(6)

Deciphera Pharmaceuticals

(6)

Guangdong Pharmaceutical

(6)

(6)

Otsuka Pharmaceutical

(6)

(6)

(6)

Xinjiang Xinziyuan Biolog

(6)

Zhejiang University

(6)

Boehringer Ingelheim Inte

(5)

Hangzhou Zhongmei Huadong

(5)

Hunan Yineng Biological M

(5)

Innovent Biologics, Suzho

(5)

Insilico Medicine

(5)

Jiangsu Hengrui Medicine;

(5)

LYNK Pharmaceuticals

(5)

Principia Biopharma

(5)

Taipei Medical University

(5)

Beijing Tide Pharmaceutic

(4)

Changchun Genescience Pha

(4)

Chongqing Medical Univers

(4)

Genzyme Corporation

(4)

Hisamitsu Pharmaceutical

(4)

Institute of Materia Medi

(4)

Janssen Pharmaceutica

(4)

Kobayashi Pharmaceutical

(4)

ROHTO Pharmaceutical

(4)

Shaanxi Maikeaote Pharmac

(4)

The Second Xiangya Hospit

(4)

(4)

Vertex Pharmaceuticals

(4)

Xizang Haisco Pharmaceuti

(4)

Ausa Pharmed Ltd; Aosa Ph

(3)

Beijing Fuyuan Pharmaceut

(3)

Beijing Innocare Pharma T

(3)

Chongqing Academy of Chin

(3)

Dewpoint Therapeutics

(3)

Halda Therapeutics OpCo

(3)

Hangzhou Arteryflow Techn

(3)

Henan Univ Of Medicine

(3)

Huayi Pharmaceutical Guan

(3)

Hubei Gedian Humanwell Ph

(3)

(3)

I Care You Biotech Co Ltd

(3)

IDEAYA Biosciences

(3)

Institute Military Medici

(3)

(3)

Ionis Pharmaceuticals

(3)

Jiangsu Carephar Pharmace

(3)

Jiangsu Hengrui Pharmaceu

(3)

Jiangsu Nhwa Pharmaceutic

(3)

Kissei Pharmaceutical

(3)

Kojin Therapeutics

(3)

Lunan Pharmaceutical Grou

(3)

Mediar Therapeutics Inc

(3)

Meilan Hangzhou Pharmaceu

(3)

Nanjing Chia-Tai Tianqing

(3)

(3)

Qilu Pharmaceutical

(3)

Revolution Medicines

(3)

Ruijin Hospital Shanghai

(3)

(3)

Shanghai East Hospital To

(3)

Shanghai Hansoh Biomedica

(3)

Shanghai Sandy Biopharmac

(3)

Takeda Pharmaceuticals

(3)

Tuojie Biotech (Shanghai)

(3)

Vigil Neuroscience

(3)

Yichang Humanwell Pharmac

(3)

Acadia Pharmaceuticals

(2)

Achieve Life Sciences Inc

(2)

Agios Pharmaceuticals

(2)

Alnylam Pharmaceuticals

(2)

Americana Pharma Llc

(2)

(2)

Averna Therapeutics Ltd

(2)

Beijing Lande Wanbang Pha

(2)

Beijing Puqi Pharmaceutic

(2)

Beijing Risuntechnology C

(2)

Bell Therapeutics

(2)

Bide Pharmatech Co Ltd

(2)

Boehringer Ingelheim Int

(2)

Bohui Biopharmaceutical Y

(2)

Botong Medical Tech Beiji

(2)

Caliway Biopharmaceutical

(2)

Cancer Hospital, CAMS

(2)

(2)

Changchun Sinobiomaterial

(2)

Changsha Stem Cell And Re

(2)

Chengdu Kanghong Pharmace

(2)

Chia Nan University of Ph

(2)

China Pharmaceutical Univ

(2)

Chong Kun Dang Pharmaceut

(2)

Click Therapeutics

(2)

Constant Therapeutics Llc

(2)

Daewoong Pharmaceutical

(2)

Daiichi Sankyo Healthcare

(2)

Dalian Medical University

(2)

Debiopharm International

(2)

Delphia Therapeutics Inc

(2)

Denali Therapeutics

(2)

Design Therapeutics

(2)

Dianthus Therapeutics

(2)

Dyno Therapeutics

(2)

(2)

(2)

First Affiliated Hospital

(2)

GlaxoSmithKline Intellect

(2)

Green Carbon Forever Tech

(2)

Guangxi University of Chi

(2)

Hangzhou Baicreat Pharma

(2)

Hangzhou Grand Biological

(2)

Hangzhou Zhongmei Huadong

(2)

Hanmi Pharmaceutical

(2)

Heyling Pharmaceutical Gu

(2)

Huashan Hospital, Fudan U

(2)

Huazhong Pharmaceutical C

(2)

Huazhong University of Sc

(2)

Hubei Huahai Gongtong Pha

(2)

Iambic Therapeutics

(2)

JW Pharmaceutical

(2)

Jewim Pharmaceutical (Sha

(2)

Jewim Pharmaceutical Rese

(2)

Jiangsu Food & Pharmaceut

(2)

Jiangsu Hengrui Medicine;

(2)

Jiangsu Hi Stone Pharmace

(2)

Jiangsu Zhiyuan Pharmaceu

(2)

Jiaxing Baimei Jihua Phar

(2)

Jilin University

(2)

(2)

Jinghua Pharmaceutical Gr

(2)

Johnson & Johnson Enterpr

(2)

Kunming Institute of Bota

(2)

Kunming Medical Universit

(2)

Lanzhou University

(2)

Lilum Therapeutics Inc

(2)

Morphic Therapeutic

(2)

Muna Therapeutics

(2)

Nanjing University of Chi

(2)

Nanjing Zeheng Pharmaceut

(2)

National Univ Hospital Si

(2)

Ningxia University

(2)

Ningxia Zhouyang Pharmace

(2)

Nona Biosciences Suzhou

(2)

Otsuka Pharma Co Ltd [jp]

(2)

PLA Air Force Medical Uni

(2)

Pasithea Therapeutics Cor

(2)

(2)

Pharmaengine Inc

(2)

(2)

Qidong Dongyue Pharmaceut

(2)

Qihe Frontier Biological

(2)

Qingdao University

(2)

Qinghai University for Na

(2)

Renibus Therapeutics

(2)

Rigel Pharmaceuticals

(2)

Servier Lab [fr]; Novarti

(2)

Servier Laboratories

(2)

Shandong Xinhua Pharmaceu

(2)

Shanghai Aobo Bio Pharmac

(2)

Shanghai Apeiron Therapeu

(2)

Shanghai Argo Biopharmace

(2)

Shanghai Aryl Pharmtech C

(2)

Shanghai Hansoh Biomedica

(2)

Shanghai Institute of Cer

(2)

Shanghai Jemincare Pharma

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Syncores Tech In

(2)

Shanghai University of Tr

(2)

Shenyang Pharmaceutical U

(2)

Shenzhen Lianxu Pharmaceu

(2)

Shijiazhuang No 4 Pharmac

(2)

Sichuan University

(2)

Simcere Pharmaceutical Co

(2)

Simcere Remediation Pharm

(2)

Sinocaber Pharmaceutical

(2)

Sinovet Jiangsu Biopharma

(2)

Souffle Therapeutics Inc

(2)

Standard Pharmaceutical R

(2)

Sun Yat-sen University

(2)

(2)

Taiho Pharmaceutical

(2)

(2)

Tianjin Polytechnic Unive

(2)

Tianjin University of Tec

(2)

Tianjin University of Tra

(2)

Tianjin University; Verta

(2)

Tyra Biosciences

(2)

Union Hospital, Tongji Me

(2)

Univ Houston System [us];

(2)

University Liaoning Tradi

(2)

Veradermics Incorporated

(2)

Wigen Biomedicine Technol

(2)

(2)

Xiangya Hospital Central

(2)

Ya Therapeutics Inc

(2)

(2)

Zhejiang Nuode Pharmaceut

(2)

Zhejiang University of Te

(2)

Zydus Lifesciences

(2)

3dmed Biomedical Shanghai

(1)

3h Pharmaceuticals Co Ltd

(1)

4e Therapeutics

(1)

858 Therapeutics

(1)

9163 0384 Quebec Inc

(1)

9494 1861 Quebec Inc

(1)

A2a Pharmaceuticals Inc

(1)

(1)

Abbisko Therapeutics

(1)

Ablynx Nv [be]; Sanofi

(1)

Academy of Military Medic

(1)

Acurex Biosciences Corp

(1)

Adcentrx Therapeutics Inc

(1)

Adlai Nortye Biopharma

(1)

Adsentex Therapeutics Inc

(1)

Affiliated Hospital Of In

(1)

Affiliated Hospital of Na

(1)

Affiliated Hospital of So

(1)

Affini T Therapeutics Inc

(1)

Agna Biopharmaceuticals I

(1)

Ahersla Health Inc [us];

(1)

Aibeile Pharmaceutical Te

(1)

Aikeruiran Hong Kong Indu

(1)

Aileens Pharma S R L

(1)

Aiweituo Jiangsu Pharmace

(1)

Aiweituo Jiangsu Pharmace

(1)

Akebia Therapeutics

(1)

(1)

Alebund Pharmaceuticals H

(1)

Alexion Pharmaceuticals

(1)

Allergan Pharmaceuticals

(1)

Allogene Therapeutics

(1)

Alnylam Pharmaceuticals I

(1)

Alpha Cognition

(1)

(1)

Amgen Research (Munich)

(1)

Amicus Therapeutics

(1)

Amunix Pharmaceuticals In

(1)

(1)

Anburui Fujian Pharmaceut

(1)

Anhui Double Crane Pharma

(1)

Anhui Haikang Pharmaceuti

(1)

Anhui Teyi Kangyang Biote

(1)

Anhui University of Chine

(1)

Anhui Yipuke Medical Tech

(1)

Anhui Zhongke Tuoran Phar

(1)

Anivance Ai Corp

(1)

(1)

(1)

Annji Pharm Co Ltd

(1)

Anomed Singapore Pte Ltd;

(1)

Antengene Biologics Ltd

(1)

Antharis Therapeutics Inc

(1)

Antiva Biosciences

(1)

Anxo Pharmaceutical

(1)

Anyong Biotechnology Inc

(1)

Aobio Pharmaceutical Co L

(1)

Aosa Pharmed Ltd

(1)

Aozhilin Beijing Biotechn

(1)

Apellis Pharmaceuticals

(1)

Apex Laboratories Private

(1)

Apogee Biotechnology Corp

(1)

Apogee Therapeutics Inc

(1)

Apollo Ap43 Ltd

(1)

Apon Zhiyuan Brain Scienc

(1)

Applied Pharmaceutical Sc

(1)

Apramitha Innovations Pri

(1)

Arentis Therapeutics Ag

(1)

Ares Trading Sa

(1)

Arite Pharmaceutical Co L

(1)

Arizest Shanghai Pharmace

(1)

Arog Pharmaceuticals

(1)

Arvinas Operations

(1)

Arvinas Operations Inc [u

(1)

Ascendis Pharma Bone Dise

(1)

(1)

Asia Pacific Global Pharm

(1)

Asocura Pharmaceuticals S

(1)

Assembly Biosciences

(1)

Astatech Chengdu Biopharm

(1)

Astatech Chengdu Biopharm

(1)

Astrid Pharma Corp

(1)

Athena Pharmaceutiques Sa

(1)

Ativa Biomedical Corp

(1)

Atom High Technology

(1)

Atossa Therapeutics

(1)

Ausa Pharmed Ltd; Shandon

(1)

Ausa Pharmed Ltd; Shenzhe

(1)

Autobio Experimental Inst

(1)

Avidity Biosciences Llc

(1)

Axsome Therapeutics

(1)

Axter Therapeutics Beijin

(1)

(1)

Azurity Pharmaceuticals I

(1)

Azvlz Pharma Inc

(1)

Baichuan Tiancheng Shaanx

(1)

Bala Therapeutics

(1)

Bashanhong Beijing Pharma

(1)

Basilea Pharmaceutica Int

(1)

BeiGene Switzerland

(1)

Beijing Beimei Pharmaceut

(1)

Beijing Biote Pharmaceuti

(1)

Beijing Caomu Liangfang C

(1)

Beijing Chaoyang Hospital

(1)

Beijing Chest Hospital Ca

(1)

Beijing Children\'s Hospi

(1)

Beijing City University

(1)

Beijing Guohua Xinye Trad

(1)

Beijing Hengtaikang Pharm

(1)

Beijing Hongjiu Life Scie

(1)

Beijing Huaxiabaicao Heal

(1)

Beijing Junda High Tech M

(1)

Beijing Jutai Biotechnolo

(1)

Beijing Kangchuanglian Bi

(1)

Beijing Kawin Technology

(1)

Beijing Liyan Siyan Biote

(1)

Beijing Puer Weiye Biolog

(1)

Beijing Qingyan Boshi Hea

(1)

Beijing Quantum Hi Tech P

(1)

Beijing Sunho Pharmaceuti

(1)

Beijing University of Chi

(1)

Beijing University; Beiji

(1)

Beijing Winsunny Pharmace

(1)

Beijing Xinghaoyingsheng

(1)

Belgrade Abella Pharma In

(1)

Bell Polyester Products I

(1)

(1)

(1)

Betta Pharmaceuticals

(1)

(1)

BioMarin Pharmaceutical

(1)

(1)

Bioasia Pharmaceutical Co

(1)

Biocad Joint Stock

(1)

Biohaven Therapeutics

(1)

(1)

(1)

Biotech Pharmaceuticals C

(1)

Biotheus Hengqin Co Ltd

(1)

Bloomage Biotechnology Co

(1)

BlossomHill Therapeutics

(1)

BlueRock Therapeutics

(1)

Blueprint Medicines

(1)

Boce Biomedical Tianjin C

(1)

Boehringer Ingelheim Vetm

(1)

Borea Therapeutics S R L

(1)

Boson Biotech Co Ltd

(1)

Bozhou Qianhe Pharmaceuti

(1)

C&c Res Lab [kr]; JW Phar

(1)

Calliditas Therapeutics

(1)

Cancer Research Tech Ltd

(1)

Cangzhou Inst Of Technolo

(1)

Canupemmune Therapeutics

(1)

Capital University of Med

(1)

Cardiolink Shenzhen Medic

(1)

Cardurion Pharmaceuticals

(1)

Carmot Therapeutics

(1)

Carnos Therapeutics Inc

(1)

Catholic Univ Industry Ac

(1)

(1)

Celgene Corp [us]; Pfizer

(1)

(1)

Celltrion Inc [kr]; Pinot

(1)

Centre For Immunology & I

(1)

Cg Pharmaceuticals Inc

(1)

Chang Gung University of

(1)

Changchun Institute of Ap

(1)

Changchun University of C

(1)

Changshan Conjuchem Bioph

(1)

Changshu Lei Yun Shang Ph

(1)

Changzhou University

(1)

Chase Therapeutics

(1)

Chemyunion Ltda

(1)

(1)

(1)

(1)

Chengdu Chipscreen Pharma

(1)

Chengdu First Pharmaceuti

(1)

Chengdu Gowell Bio Pharma

(1)

Chengdu Kuachangaopu Medi

(1)

Chengdu Renqing Yishou Ph

(1)

Chengdu Saien Jinuo Biote

(1)

Chengdu Saijing Biopharma

(1)

Chengdu Shibeikang Biomed

(1)

Chengdu Tailibei Pharmace

(1)

Chengdu Yazhong Bio Pharm

(1)

Chengtu Intelligent Tech

(1)

China Academy of Chinese

(1)

China Electric Power Rese

(1)

China Japan Friendship Ho

(1)

China Nat Offshore Oil Co

(1)

China Pharmaceutical Univ

(1)

China Resources Sanjiu Ta

(1)

China State Inst Of Pharm

(1)

Chinese University of Hon

(1)

Chongqing Apu Gelei Biote

(1)

Chongqing Huasen Yingnuo

(1)

Chongqing Shiquan Ecologi

(1)

Chongqing Univ Of Chinese

(1)

Chongqing Xinongdakexin A

(1)

Chunan First People\'s Ho

(1)

Chung Shan Medical Univ H

(1)

Chupu Chuangzhi Wuhan Pha

(1)

Cie Laitiere Europeenne

(1)

Cinclus Pharma Holding AB

(1)

Cisen Pharmaceutical Co L

(1)

Clearmy Labs Inc

(1)

Colgate-Palmolive

(1)

Concept To Medicine Biote

(1)

Consort Biosciences Man I

(1)

Corcept Therapeutics

(1)

CosMED Pharmaceutical

(1)

Cosmo Technologies

(1)

Covidien Pharmaceuticals

(1)

Crick Therapeutics Ltd

(1)

Cspc Zhongqi Pharmaceutic

(1)

Cstone Pharmaceuticals Su

(1)

Curadev Pharma Pvt Ltd

(1)

Cytosite Biopharma

(1)

D & D Pharma Tech Inc

(1)

(1)

Daewoong Pharmaceutical C

(1)

Dahan Pharmaceutical Hena

(1)

(1)

Dalian Institute of Chemi

(1)

Dana-Farber Cancer Instit

(1)

Daoyi Youdao Tianjin Phar

(1)

Daqing Xingmu Tech Co Ltd

(1)

Dennert William [us]; Den

(1)

(1)

Dhanoa Daljit Singh

(1)

(1)

(1)

Direct Biologics

(1)

Disarm Therapeutics

(1)

(1)

(1)

Duality Biologics Shangha

(1)

Duality Biologics Suzhou

(1)

Duscentis Biotherapeutics

(1)

ENSEM Therapeutics

(1)

East China Normal Univers

(1)

East China Normal Univers

(1)

Eidos Therapeutics

(1)

Eindhoven University of T

(1)

Eisai R&D Management

(1)

Electric Power Science Re

(1)

Eliaz Therapeutics Inc

(1)

(1)

En Otsuka Pharmaceutical

(1)

Enalare Therapeutics

(1)

Enanta Pharmaceuticals

(1)

Encoded Therapeutics

(1)

(1)

Endocell Therapeutics Inc

(1)

Enkang Pharmaceutical Tec

(1)

Enterobiome Inc

(1)

Esapharma S P A

(1)

Esperion Therapeutics

(1)

Eun Woo Pharm Co Ltd

(1)

Eustralis Pharmaceuticals

(1)

Exam Therapeutics Inc

(1)

Exoone Bio Co Ltd

(1)

Eye Hospital of China Aca

(1)

(1)

Fameccanica Data

(1)

Fang Zhang Hong

(1)

Feierfulai Biological Co

(1)

Feiman Changchun Pharmace

(1)

Fermenta Biotech Ltd

(1)

Fibrocor Therapeutics Inc

(1)

First Affiliated Hospital

(1)

First Affiliated Hospital

(1)

First People\'s Hospital

(1)

Flagship Pioneering Innov

(1)

Foreseen Technology Beiji

(1)

Formosa Laboratories Inc

(1)

Fortvita Biologics Inc

(1)

Forward Therapeutics Inc

(1)

Foshan Qihuang Chengkang

(1)

Fresenius Kabi USA

(1)

Frontier Pharmaceuticals

(1)

Fudan University

(1)

Fujian Rst Tech Co Ltd

(1)

(1)

Futuregen Biopharmaceutic

(1)

Fuzhou Neptunus Fuyao Pha

(1)

Fuzhou Tianweida Informat

(1)

(1)

GE Precision Medicine

(1)

GH Research, Ireland

(1)

Gan & Lee Pharmaceuticals

(1)

Gansu Keju Pharmaceutical

(1)

Gansu Normal Univ For Nat

(1)

(1)

Genchem & Genpharm Changz

(1)

Genentech Inc [us]; BioNT

(1)

Genentech Inc [us]; Ferma

(1)

Genentech Inc [us]; Hoffm

(1)

Genentech Inc [us]; Regor

(1)

Genentech Inc [us]; Xenco

(1)

Genfleet Therapeutics Sha

(1)

Genmab As [dk]; BioNTech

(1)

Genmab As [dk]; T O A D O

(1)

Gento Pharmaceutical Co L

(1)

Georgia Tech Research Cor

(1)

Gewu Bio Co Ltd

(1)

Gilgamesh Pharmaceuticals

(1)

(1)

Glaxosmithkline Intellect

(1)

Global Blood Therapeutics

(1)

Glory Age Co Ltd

(1)

Governing Council Univ To

(1)

Green Cross Corp [kr]; Ha

(1)

(1)

Guangdong Anjian Pharmace

(1)

Guangdong HEC Pharmaceuti

(1)

Guangdong Hongshanhu Phar

(1)

Guangdong Kingfa Scientif

(1)

Guangdong Lanyu Biotechno

(1)

Guangdong Wanguan Pharmac

(1)

Guangdong Xianfanggu Tech

(1)

Guangdong Yangble Biophar

(1)

Guangxi Chuanji Yiyangjin

(1)

Guangxi Normal University

(1)

Guangxi Zhongzhitong Info

(1)

Guangzhou Baiyunshanzhong

(1)

Guangzhou Chuangrui Healt

(1)

Guangzhou Communications

(1)

Guangzhou Daguang Pharmac

(1)

Guangzhou Hanfang Pharmac

(1)

Guangzhou Hanmay Cosmetic

(1)

Guangzhou Jinan Univ Biop

(1)

Guangzhou Joyo Pharmatech

(1)

Guangzhou Medical Univers

(1)

Guangzhou Runlin Pharmace

(1)

Guangzhou University of C

(1)

Guangzhou Yajia Innovatio

(1)

Guangzhou Yuezhilian Inte

(1)

Guangzhou Zhenyantang Pha

(1)

Guilin University of Elec

(1)

Guizhou Jinqianguo Biotec

(1)

Guizhou Natural Product R

(1)

Guizhou University of Tra

(1)

Guizhou Weikang Zifan Pha

(1)

Guizhou Xijiu; Tianjin Un

(1)

Gulang County Heisongyi T

(1)

Guozhong Kangjian Beijing

(1)

Haichang Biotech Co Ltd

(1)

Hainan Meien Kangxin Medi

(1)

Hainan Simcere Zaiming Ph

(1)

Haisco Pharmaceutical Gro

(1)

Halia Therapeutics Inc

(1)

(1)

Hanghzou Bio Sincerity Ph

(1)

Hangzhou China Resources

(1)

Hangzhou Chunhetang Healt

(1)

Hangzhou City Xiaoshan Di

(1)

Hangzhou First People\'s

(1)

Hangzhou Fst Pharmaceutic

(1)

Hangzhou Fukadi Biologica

(1)

Hangzhou Ganzhicao Tech C

(1)

Hangzhou Guorui Biotechno

(1)

Hangzhou Hospital of Trad

(1)

Hangzhou Jianhai Tech Co

(1)

Hangzhou Jiechuangrui Med

(1)

Hangzhou Just Biotherapeu

(1)

Hangzhou Lionser Medical

(1)

Hangzhou Maidong Shukang

(1)

Hangzhou Polymed Biopharm

(1)

Hangzhou Shengyu Biomedic

(1)

Hangzhou Xianweida Biotec

(1)

Hangzhou Youjia Biomedica

(1)

Hanshou Hegang New Energy

(1)

Hansoh Bio Llc [us]; Shan

(1)

Hansoh Shanghai Health Te

(1)

Harbin Pharmaceutical Gro

(1)

(1)

Health Biomed Co Ltd

(1)

Health On Aging Bvba; Uni

(1)

Heartseed Inc; Keio Oki

(1)

Hebei Anguo Zhenyu Pharma

(1)

Hebei Anjian Chengyi Phar

(1)

Hebei University of Techn

(1)

Hebei University of Techn

(1)

Hebei Wanbang Folon Pharm

(1)

Hefei Institutes of Physi

(1)

Hefei Tiangang Immunology

(1)

Heidelberg Pharma Researc

(1)

Heilongjiang Bayi Agricul

(1)

Heilongjiang Dilong Pharm

(1)

Helix Nanotechnologies

(1)

Henan Cancer Hospital; Th

(1)

Henan Kujiukang Medicine

(1)

Henan Mingrui Pharmaceuti

(1)

Henan University

(1)

Henan University Huaihe H

(1)

Henghau Enterprise Co Ltd

(1)

Hengjing Hechuang Biologi

(1)

Hepaitech Beijing Biophar

(1)

Hepion Pharmaceuticals In

(1)

Hexin Saier Suzhou Cell B

(1)

Heze Haoyuan Pharmaceutic

(1)

High Point Univ

(1)

Hoffmann La Roche [ch]; C

(1)

Hoffmann La Roche [ch]; R

(1)

Hoffmann-La Roche

(1)

(1)

(1)

Hsj Achievement Conversio

(1)

Huaneng Lancang River Hyd

(1)

Huang Chen Hsuan

(1)

(1)

Huanggang Normal Universi

(1)

Huanghuai University

(1)

Huapu Shijiazhuang Pharma

(1)

Huayi Taikang Pharmaceuti

(1)

Huayu Biotechnology (Tian

(1)

Huazhong University of Sc

(1)

Hubei Guangren Medicament

(1)

Hubei Jiangxia Laboratory

(1)

Hubei Lingsheng Pharmaceu

(1)

Hubei Merryclin Pharmaceu

(1)

Hubei Provincial Center f

(1)

Hubei Waterstone Bio Phar

(1)

Hubei Xili Pharmaceutical

(1)

Hubei Yinuorui Biological

(1)

Hubei Zhongyao Pharmaceut

(1)

Huiying Hubei Environment

(1)

Hunan Aikesong Health Man

(1)

Hunan Dongjian Pharmaceut

(1)

Hunan Huixin Pharmaceutic

(1)

Hunan Maiji Biotechnology

(1)

Hunan Normal University;

(1)

Hunan Shangcheng Biotechn

(1)

Huzhou City Linghu Xinwan

(1)

Huzhou Zhanwang Pharmaceu

(1)

IP2IPO Innovations

(1)

Idorsia Pharmaceuticals

(1)

Ignis Therapeutics Suzhou

(1)

Ilesio Therapeutics Inc

(1)

Ilko Ilac Sanayi Ve Ticar

(1)

Immuneoncia Therapeutics

(1)

(1)

Impact Therapeutics Inc

(1)

Impleson Pharmaceuticals

(1)

Incarved Co Ltd

(1)

Industry-university Coope

(1)

Inner Mongolia Normal Uni

(1)

Inner Mongolia People\'s

(1)

Inner Mongolia Research I

(1)

Inner Mongolia University

(1)

Innovec Biotherapeutics

(1)

Innovik Biotech Hong Kong

(1)

Innovstone Therapeutics

(1)

Inspection Therapeutics I

(1)

Inst For Basic Science [k

(1)

Inst Materia Medica Cams

(1)

Inst Med Biotechnology Ca

(1)

Institute of Chinese Mate

(1)

Institute of Materia Medi

(1)

Institute of Microbiology

(1)

Institute of Microbiology

(1)

Intellia Therapeutics

(1)

Intellus Biotherapeutics

(1)

(1)

(1)

Ireland 790 Co Ltd

(1)

Isomorphic Labs Ltd

(1)

Itf Res & Pharma Inc

(1)

Itf Res Pharma Slu

(1)

Jacoray Pharmaceutical Te

(1)

Janssen Pharmaceuticals

(1)

Jasper Therapeutics

(1)

Javier Rene Dumalaog

(1)

Jazz Pharmaceuticals Irel

(1)

Jeil Pharmaceutical Co Lt

(1)

Ji Yan Biomedical Co Ltd

(1)

Jiajin Biological Medicin

(1)

Jianchangbang Chinese Her

(1)

Jianghan University

(1)

Jiangnan University; Jian

(1)

Jiangsu Chia Tai Fenghai

(1)

Jiangsu Chuangte Pharmace

(1)

Jiangsu College of Nursin

(1)

Jiangsu Flag Chemical Ind

(1)

Jiangsu Handian Biotechno

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengrui Pharmaceu

(1)

Jiangsu Hengrui Pharmaceu

(1)

Jiangsu Jiahao Hot Melt A

(1)

Jiangsu Jiming Pharmaceut

(1)

Jiangsu Jinglixin Pharmac

(1)

Jiangsu Leeway Biological

(1)

Jiangsu Nuoge Biotechnolo

(1)

Jiangsu Pacific Meinuoke

(1)

Jiangsu Province Hospital

(1)

Jiangsu Province Hospital

(1)

Jiangsu Puxin Pharmaceuti

(1)

Jiangsu Rongzhitang Biolo

(1)

Jiangsu Szyy Pharmaceutic

(1)

Jiangsu University; Shang

(1)

Jiangsu Webest Medical Pr

(1)

Jiangsu Wuzhong Pharmaceu

(1)

Jiangsu Xidian Pharmaceut

(1)

Jiangsu Yabang Aipusen Ph

(1)

Jiangsu Yahong Meditech C

(1)

Jiangxi Disainuo Pharmace

(1)

Jiangxi Guangenhe Pharmac

(1)

Jiangxi Kerui Pharmaceuti

(1)

Jiangxi Lishikaoxian Zhul

(1)

Jiangxi Qingchun Kangyuan

(1)

Jiangxi Sincer Medical Co

(1)

Jiangyin Huacai Shijia Ne

(1)

Jiaozuo Furuitang Pharmac

(1)

Jilin Xiansu Pharmaceutic

(1)

Jilin Xiuzheng Pharmaceut

(1)

Jiming Pharmatech Suzhou

(1)

Jinan Micro Ecological Bi

(1)

Jinan Sanyuan Pharmaceuti

(1)

Jinan Tianju Animal Husba

(1)

Jinan University

(1)

Jinan University; Guangdo

(1)

Jing Brand; Jinpai Chizhe

(1)

Jingzhou Central Hospital

(1)

Jinhua Herui Life Health

(1)

Jinhua Longevity Valley B

(1)

Jinyao Heping Tianjin Pha

(1)

Jinzhong Comprehensive In

(1)

Jiujiang Hi Tech Pharmace

(1)

Johns Hopkins University

(1)

Jsk Biotech Inc

(1)

(1)

Junkang Medical Tech Tian

(1)

K36 Therapeutics

(1)

Kadmon Corporation Llc

(1)

Kangbaida (Sichuan) Biote

(1)

(1)

Kestrel Therapeutics Inc

(1)

Keymed Biosciences Chengd

(1)

(1)

Kongdi Internet Tech Co L

(1)

Korea Inst Of Science And

(1)

Korea University Research

(1)

Kumquat Biosciences

(1)

Kunming Institute of Zool

(1)

Kunming Lifeng Practical

(1)

Kunming University of Sci

(1)

Kunyu Health Pharmaceutic

(1)

(1)

(1)

LTS Lohmann Therapie-Syst

(1)

LaNova Medicines

(1)

Laboratorios Farmaceutico

(1)

Laboratory for Synthetic

(1)

Laekna Pharmaceutical Nin

(1)

Laekna Therapeutics, Shan

(1)

Laikai Pharmaceutical Nin

(1)

Laikai Pharmaceutical Tec

(1)

Lankenau Inst For Medical

(1)

Lantern Pharma Inc

(1)

Lanzhou Institute Husband

(1)

Laoshan National Laborato

(1)

Lask Pharma Inc

(1)

Launxp Biomedical Co Ltd

(1)

Lb Pharmaceuticals Inc

(1)

Lenz Therapeutics Operati

(1)

Levena Suzhou Biopharma C

(1)

Lexiao Liaoning Nano Biot

(1)

(1)

(1)

Liaoning Cancer Hospital

(1)

Liaoning Misentang Pharma

(1)

Liaoning Oxiranchem Pharm

(1)

Lifeedit Therapeutics

(1)

(1)

Linyi Kangli Medical Equi

(1)

Lion Corporation

(1)

Liupanshui Animal Health

(1)

Livzon New North River Ph

(1)

Lixiang Weilai Dezhou Pla

(1)

Lonza Greenwood Llc

(1)

Lospoint Therapeutics Inc

(1)

Ltt Bio Pharma Co Ltd [jp

(1)

(1)

(1)

Lyu Genquine Biomedical U

(1)

M Path Biopharma Ltd

(1)

(1)

Mackay Memorial Hospital

(1)

(1)

Maha Therapeutics Inc

(1)

(1)

Marengo Therapeutics

(1)

Mariana Oncology

(1)

(1)

Marsal Therapeutics Inc

(1)

(1)

Matery Biotech Co Ltd

(1)

Max Delbrück Center for

(1)

Medicalsystem Biotechnolo

(1)

Medigen Biotechnology Cor

(1)

Medilink Therapeutics, Su

(1)

(1)

(1)

Medshine Discovery

(1)

Meiji Holdings Co Ltd

(1)

Mello Biotech Taiwan Co L

(1)

(1)

Merdury Biopharmaceutical

(1)

(1)

Meta Therapeutics Inc

(1)

Microcirculation Inst Chi

(1)

(1)

Mirati Therapeutics

(1)

Mitchell International

(1)

Mitoimmune Therapeutics

(1)

Mitsubishi Tanabe Pharma

(1)

(1)

Monolithic Cell Therapeut

(1)

Mosanna Therapeutics Ag

(1)

Multiverse Pharma Inc

(1)

(1)

NGM Biopharmaceuticals

(1)

Nanjing Anmei Pharmaceuti

(1)

Nanjing City Gulou Distr

(1)

Nanjing Feilikang Pharmac

(1)

Nanjing Fisheries Researc

(1)

Nanjing Hailing Pharmaceu

(1)

Nanjing Hanxin Pharmaceut

(1)

Nanjing Heron Pharmaceuti

(1)

Nanjing Huihong Pharmaceu

(1)

Nanjing Indetek Laborator

(1)

Nanjing Jiangning Hospita

(1)

Nanjing Lingxin Biotechno

(1)

Nanjing Medical Universit

(1)

Nanjing Polytechnic Insti

(1)

Nanjing Qingpu Biotechnol

(1)

Nanjing Sanhome Pharmaceu

(1)

Nanjing Tongnuokang Medic

(1)

Nanjing Vcare Bio Pharmac

(1)

Nanjing Well Pharmaceutic

(1)

Nanjing Xinbai Pharmaceut

(1)

Nanjing Xingyin Pharmaceu

(1)

Nanjing Zhihe Pharmaceuti

(1)

Nanjing Zhongkebaier Phar

(1)

Nanjing Zhongkebaier Phar

(1)

Nankai University

(1)

Nantong Huashan Pharmaceu

(1)

Nantong Huaxiang Pharmace

(1)

National Cheng Kung Unive

(1)

National Defense Medical

(1)

National Health Res Inst

(1)

National Health Research

(1)

National Inst For Communi

(1)

National Research Institu

(1)

National Taiwan Universit

(1)

National Taiwan Universit

(1)

Navigo Proteins

(1)

(1)

Neuboron Medtech Res Inst

(1)

Neurocrine Biosciences

(1)

Neuromusculoskeletal Rege

(1)

(1)

Ningbo Cixi Inst Of Biome

(1)

Ningbo Ocean Pharmaceutic

(1)

Ningbo Yuanxin Electronic

(1)

Ningde Contemporary Amper

(1)

Ningxia Tianxin Pharmaceu

(1)

Nippon Chemiphar Co

(1)

Nippon Shinyaku

(1)

Nitrase Therapeutics Inc

(1)

Nkilt Therapeutics Inc

(1)

(1)

(1)

Noobs Therapeutics Inc

(1)

North China University of

(1)

Northridge Health Group H

(1)

Northwestern University

(1)

Novartis Pharma

(1)

Novelwise Pharmaceutical

(1)

(1)

Nuoyataier Medical Tech S

(1)

Nurix Therapeutics Inc [u

(1)

Nvida Therapeutics Inc

(1)

Nykode Therapeutics

(1)

(1)

(1)

Ocean Alchemists Llc

(1)

Odesai Therapeutics Inc

(1)

Odyssey Therapeutics

(1)

Oncopia Therapeutics Inc

(1)

Oncopia Therapeutics Inc

(1)

Opko Biologics Ltd

(1)

(1)

Optima Pharmaceuticals Ll

(1)

Orphai Therapeutics Inc

(1)

Osprey Biopharmaceuticals

(1)

Osta Therapeutics [fr]; C

(1)

Oyster Point Pharma

(1)

PTC Therapeutics

(1)

Panzhihua Hospital of Chi

(1)

Parabilis Pharmaceuticals

(1)

Paragon Therapeutics

(1)

Paragon Therapeutics Inc

(1)

(1)

Park Strategic Venture Gr

(1)

Passage Bio Inc

(1)

Pegavision Corp [tw]; Fac

(1)

Persio Pharmaceuticals In

(1)

Pfizer [us]; CTXT Pty LTD

(1)

(1)

(1)

Pheast Therapeutics Inc

(1)

(1)

Phytotechai Co Ltd

(1)

Ping An Shionogi Co Ltd

(1)

Pliant Therapeutics

(1)

Postech Research and Busi

(1)

Precise Biopharma Pvt Ltd

(1)

President And Fellows Of

(1)

Proya Cosmetics

(1)

(1)

(1)

Qide Pharmaceutical Tech

(1)

Qilu Animal Health Produc

(1)

Qilu Pharmaceutical Co Lt

(1)

Qilu Pharmaceutical; Shan

(1)

Qilu University of Techno

(1)

Qin Jingran; Wenzhou Nanh

(1)

Qingdao Biotemed Biomater

(1)

Qingdao Inst Marine Geolo

(1)

Qingdao Municipal Hospita

(1)

Qingdao Shuojing Biologic

(1)

Qingdao Traditional Chine

(1)

Qingdao Xingsai Biotechno

(1)

Quantum Science

(1)

Quantx Biosciences Us Inc

(1)

Quanzhou Haichuang Pharma

(1)

Queen Mary University of

(1)

Quzhou People\'s Hospital

(1)

RaQualia Pharma

(1)

Ractigen Therapeutics

(1)

Radionetics Oncology Inc

(1)

Ramot At Tel Aviv Univ Lt

(1)

Ratio Therapeutics Inc

(1)

(1)

Rdp Pharma Ag [ch]; Juliu

(1)

Reata Pharmaceuticals Hol

(1)

(1)

Reel Therapeutics Inc

(1)

Regeneron Pharma [us]; Se

(1)

Regents of the University

(1)

Regor Pharmaceuticals Inc

(1)

Regor Pharmaceuticals Inc

(1)

Regulus Therapeutics

(1)

Relay Therapeutics

(1)

Renji Hospital Shanghai J

(1)

Repurposed Therapeutics I

(1)

Restor Pharmaceuticals

(1)

(1)

Rgenta Therapeutics

(1)

Rigerna Therapeutics Beij

(1)

Ring Pharmaceuticals Inc

(1)

Ringpu Tianjin Bio Pharm

(1)

Roche Diabetes Care Gmbh

(1)

Rohto Pharma [jp]; Innoji

(1)

Rondo Therapeutics Inc

(1)

Roquefort Therapeutics Pl

(1)

Rqvi Life Sciences Corp;

(1)

Ruijin Hospital Shanghai

(1)

Ruijin Hospital Shanghai

(1)

Ruijin Hospital Shanghai

(1)

(1)

ST Superiore Di Sanita [i

(1)

Saiweitai Guangzhou Healt

(1)

Salubris Chengdu Biotech

(1)

Sam A Pharm Co Ltd

(1)

Samyang Corporation

(1)

Sangamo Therapeutics

(1)

Sanming No 2 Hospital

(1)

Country

X

China Patent News

Taiwan Patent News

European Patent News

Status

X

1 - 100 of 1944 Items

Sign In / Subscribe

Select All

Share
Download as Excel
Download as PDF

Taiwan Patent Office Publishes Revolution Medicines Patent Application for RAS Inhibitors

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has published Revolution Medicines patent application for RAS Inhibitors. The invention was developed by Alachouzos Georgios, Madej Benjamin D, Koltun Elena S, Edwards Anne V, Thompson Severin, Pota Kristof, Luu Nguyen Hong Quang, Tye Mark, Gill Adrian L, Latimer Bernadette K, Burnett G Le..

Taiwan Patent Office Receives AstraZeneca AB Patent Application for Polq Inhibitors

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has received AstraZeneca AB patent application for Polq Inhibitors. Barlaam Bernard, Turner Oliver, Jones Helen Elizabeth, Ferrer Cabrera Sofia, Wrigley Gail, Shields Jason, Gopalsamy Arimala and Bodnarchuk Michael developed the invention. The patent application number is TW20250120408 ..

BioAge Labs Files Taiwan Patent Application for Inhibitors of NLRP3 Inflammasome

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- BioAge Labs has filed a patent application for Inhibitors of NLRP3 Inflammasome. This invention was developed by Wilhelmsen Kevin, Humphries Paul, Geyer Matthias, Wang Yan, Montgomery Rusty and Hartman George. The patent application number is TW20250111211 20250325. The patent publication number is TW202547..

Jinan University; Guangdong Yanmei Biotechnology Co Ltd and Guangzhou Beiyan Biotechnology Co Ltd Submit Chinese Patent Application for Polypeptide for Promoting Collagen Synthesis..

Pharmaceutical

| Wed 17 Jun 2026

Beijing, June 17 -- Jinan University; Guangdong Yanmei Biotechnology Co Ltd and Guangzhou Beiyan Biotechnology Co Ltd have submitted a patent application for Polypeptide for Promoting Collagen Synthesis and Application Thereof. This invention was developed by Li Xiaobin, Xiong Sheng, Chen Wei, Xie Qiuling, Wang Yiting, Chen Hong..

State Intellectual Property Office of China Releases Shanghai Jiao Tong University and Shanghai Jiao Tong University Sichuan Research Institute Patent Application for Step-by-step ..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has released Shanghai Jiao Tong University and Shanghai Jiao Tong University Sichuan Research Institute patent application for Step-by-step Injection Control System of Multistage Injection Device with Ultrahigh Compression Ratio. This invention was developed by Huan..

Taiwan Patent Office Releases Otsuka Pharma Co Ltd and Riken Patent Application for Mesenchymal Cells of Ventral Hindgut Mesoderm and Method for Producing Same

Pharmaceutical

| Thu 18 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has released Otsuka Pharma Co Ltd and Riken patent application for Mesenchymal Cells of Ventral Hindgut Mesoderm and Method for Producing Same. This invention was developed by Satoh Taiki and Takasato Minoru. The patent application number is TW20250107533 20250227. The patent publicatio..

State Intellectual Property Office of China Releases Intellus Biotherapeutics Inc Patent Application for Gene Editing Composition of Polypeptide and Nucleic Acid and Application Th..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has released Intellus Biotherapeutics Inc patent application for Gene Editing Composition of Polypeptide and Nucleic Acid and Application Thereof. This invention was developed by Johnson Paul R and S J Dooley. The patent application number is CN20248045905 202405..

State Intellectual Property Office of China Releases Nanjing Xinbai Pharmaceutical Co Ltd Patent Application for Sterilizing and Filtering Equipment and Method for Multivitamins fo..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has released Nanjing Xinbai Pharmaceutical Co Ltd patent application for Sterilizing and Filtering Equipment and Method for Multivitamins for Injection. This invention was developed by Zhang Kui, Shen Liyun and Lu Qian. The patent application number is CN20251169..

State Intellectual Property Office of China Releases Hunan Dongjian Pharmaceutical Co Ltd Patent Application for Glue Solution Impurity Precipitation Device and Process for Tortois..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has released Hunan Dongjian Pharmaceutical Co Ltd patent application for Glue Solution Impurity Precipitation Device and Process for Tortoise-shell Glue Production. This invention was developed by Ma Hao, Luo Pei and Zhang Mingwei. The patent application number i..

State Intellectual Property Office of China Releases Wuhan Guanggu Humanwell Biological Medicine Co Ltd and Hubei Bio Pharmaceutical Industrial Technological Institute Inc Patent A..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has released Wuhan Guanggu Humanwell Biological Medicine Co Ltd and Hubei Bio Pharmaceutical Industrial Technological Institute Inc patent application for Application of Pudk-hgf Injection. This invention was developed by Yang Jian, Li Chunqing, Jiang Yufei, Hu Jing..

State Intellectual Property Office of China Releases Jiangsu Hengrui Medicine and Shanghai Shengdi Pharmaceutical Co Ltd Patent Application for BTN3A Binding Protein and Medical Ap..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has released Jiangsu Hengrui Medicine and Shanghai Shengdi Pharmaceutical Co Ltd patent application for BTN3A Binding Protein and Medical Application Thereof. This invention was developed by Wang Huan, Gao Han, Zheng Xin, Zhang Chongqi, Lin Yuan, Su Lu and Liao Chen..

State Intellectual Property Office of China Releases Zhuliuyuan Biotechnology Shanghai Co Ltd and Zhongshan Zhuliuyuan Biotechnology Co Ltd Patent Application for Peptide of Target..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has released Zhuliuyuan Biotechnology Shanghai Co Ltd and Zhongshan Zhuliuyuan Biotechnology Co Ltd patent application for Peptide of Targeted Somatostatin Receptor, Coupling Medicine and Application of Peptide and Coupling Medicine. This invention was developed by ..

State Intellectual Property Office of China Releases Rqvi Life Sciences Corp and Archiway Pharma Uk Ltd Patent Application for Composition Comprising Cytisine for Use in Treating a..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has released Rqvi Life Sciences Corp and Archiway Pharma Uk Ltd patent application for Composition Comprising Cytisine for Use in Treating and/or Preventing Addiction in Subjects in Need Thereof. This invention was developed by C A Jacobs, Gain David F and Clark Ala..

State Intellectual Property Office of China Releases Impleson Pharmaceuticals Inc Patent Application for Prevention, Inhibition or Treatment of Conditions or Conditions Mediated by..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has released Impleson Pharmaceuticals Inc patent application for Prevention, Inhibition or Treatment of Conditions or Conditions Mediated by Urocanic Acid Reductase. This invention was developed by Beck Karl, Backhed Fredrik and Westerlund Christer. The patent ap..

State Intellectual Property Office of China Releases Ring Pharmaceuticals Inc Patent Application for Cyclin Inhibitors

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has released Ring Pharmaceuticals Inc patent application for Cyclin Inhibitors. This invention was developed by Bokus Andrew T, Walton Bradley F, Crearte Solas Cristina, Aggen James Bradley, Shapiro Jason A, Demat Marc, Dupay Nicholas John, Leong Steve Foo Shui, Bat..

State Intellectual Property Office of China Releases Lixiang Weilai Dezhou Plasma Tech Co Ltd Patent Application for Plasma Generator and Traditional Chinese Medicine Disinsection ..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has released Lixiang Weilai Dezhou Plasma Tech Co Ltd patent application for Plasma Generator and Traditional Chinese Medicine Disinsection Device Thereof. This invention was developed by Sun Baojing, Hu Xiaolong and Zhang Wei. The patent application number is CN..

Taiwan Patent Office Releases Rondo Therapeutics Inc Patent Application for Bispecific Antibodies That Bind to CD28 and Nectin-4

Pharmaceutical

| Thu 18 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has released Rondo Therapeutics Inc patent application for Bispecific Antibodies That Bind to CD28 and Nectin-4. This invention was developed by Rueger Katja, Rangaswamy Udaya, Force Aldred Shelley, Chen Elaine, Trinklein Nathan, Clarke Starlynn, Kaur Manpreet, Davison Laura M and Harris K..

Taiwan Patent Office Releases Immuneoncia Therapeutics Inc and Yuhan Patent Application for Anti-tigit/anti-pd-l1 Bispecific Antibody and Use Thereof

Pharmaceutical

| Thu 18 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has released Immuneoncia Therapeutics Inc and Yuhan patent application for Anti-tigit/anti-pd-l1 Bispecific Antibody and Use Thereof. This invention was developed by Lee Eun-jung, Park Young-bong, Jung Hee-ra, Kim Dong-kyun, Park Ji-eun, Kim Sung-ho, Jee Min-hyeok, Kim Jun-hwan, Ahn Byeong..

State Intellectual Property Office of China Releases Xiamen Urban Planning & Design Institute Co Ltd, Xiamen Witbee Tech Co Ltd, Tianjin University and Fujian Shuizijie Tech Co Ltd..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has released Xiamen Urban Planning & Design Institute Co Ltd, Xiamen Witbee Tech Co Ltd, Tianjin University and Fujian Shuizijie Tech Co Ltd patent application for Digital Intelligence Scene Enabling Canal Heritage Land Utilization Decision-making Method and System...

Taiwan Patent Office Releases Mediar Therapeutics Inc Patent Application for Anti-ephrin B2 Antibodies and Methods of Use

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has released Mediar Therapeutics Inc patent application for Anti-ephrin B2 Antibodies and Methods of Use. This invention was developed by Tavares Daniel, Higginson-scott Nathan, Espelin Christopher, Devine Erin, Yaworsky Paul and Kiprono Timothy. The patent application number is TW20250..

State Intellectual Property Office of China Releases Xi'an Institute of Optics and Precision Mechanics, CAS and Shanghai Jiao Tong University Patent Application for Double-energy-p..

Pharmaceutical

| Wed 17 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has released Xi'an Institute of Optics and Precision Mechanics, CAS and Shanghai Jiao Tong University patent application for Double-energy-point Double-magnification Imaging Device and Method Based on Time-broadening Framing Camera. This invention was developed by W..

Taiwan Patent Office Releases Visirna Therapeutics Suzhou Co Ltd Patent Application for RNA Inhibitors for Inhibiting Insulin-lke Growth Factor 1 Receptor Expression

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has released Visirna Therapeutics Suzhou Co Ltd patent application for RNA Inhibitors for Inhibiting Insulin-lke Growth Factor 1 Receptor Expression. This invention was developed by Lu Jian-yu, Gao Cui-cui, Zou Xiaoming, He Hui-jun, Wang Ming-jie and He Qionger. The patent application n..

Taiwan Patent Office Releases University Kagoshima and Surv Biopharma Inc Patent Application for Oncolytic Virus and Cancer Treatment Using Same

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has released University Kagoshima and Surv Biopharma Inc patent application for Oncolytic Virus and Cancer Treatment Using Same. This invention was developed by Watanabe Maki, Kosai Ken-ichiro, Nishikawaji Yuya and Matsuda Eriko. The patent application number is TW20250102532 20250121. ..

Taiwan Patent Office Releases Otsuka Pharma Co Ltd and Riken Patent Application for Sheet-like Cell Culture and Method for Producing Same

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has released Otsuka Pharma Co Ltd and Riken patent application for Sheet-like Cell Culture and Method for Producing Same. This invention was developed by Ofuji Kazuhiro and Takasato Minoru. The patent application number is TW20250105544 20250214. The patent publication number is TW20254..

Taiwan Patent Office Releases Hsing Yu Hsien Patent Application for Application of Pharmaceutical Composition in Preparation of Medicines and Health Products for Accelerating Sober..

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has released Hsing Yu Hsien patent application for Application of Pharmaceutical Composition in Preparation of Medicines and Health Products for Accelerating Sobering-up, Alleviating Hangover Symptoms, and Combination Thereof Having No Adverse Side Effects and Being Suitable for Frequent U..

Taiwan Patent Office Releases Signet Therapeutics Inc Patent Application for Compound and Medical Use Thereof

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has released Signet Therapeutics Inc patent application for Compound and Medical Use Thereof. This invention was developed by Peng Hua-ling, Li Lin, Zhang Hai-sheng, Huang Ya-ping, Zhuo Shu, Chen Yu, Cheng Hui-min, Dai Chang-gui and Chen Jie. The patent application number is TW202501202..

State Intellectual Property Office of China Publishes Zhaohua Biotechnology Xi'an Co Ltd Patent Application for Traditional Chinese Medicine Grinding Device for Traditional Chinese..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has published Zhaohua Biotechnology Xi'an Co Ltd patent application for Traditional Chinese Medicine Grinding Device for Traditional Chinese Medicine Mask Mud Processing. The invention was developed by He Jugui. The patent application number is CN20251206075 2025..

State Intellectual Property Office of China Publishes Jiangsu Webest Medical Product Co Ltd Patent Application for Wall-mounted Foldable Infusion Liquid Medicine Suspension Bracket

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has published Jiangsu Webest Medical Product Co Ltd patent application for Wall-mounted Foldable Infusion Liquid Medicine Suspension Bracket. The invention was developed by Chen Zhongbo, Chen Xiaobao, Cheng Zhou, Chen Chunbing, Liang Guangju and Sun Yuezhou. The ..

State Intellectual Property Office of China Publishes Jiujiang Hi Tech Pharmaceutical Tech Co Ltd Patent Application for Sodium Polyacrylate Composite Poloxamer Gel and Preparation..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has published Jiujiang Hi Tech Pharmaceutical Tech Co Ltd patent application for Sodium Polyacrylate Composite Poloxamer Gel and Preparation Process Thereof. The invention was developed by Liu Yanan, Qu Qianliang, Qu Qianbin, Peng Bin and Qu Guang. The patent app..

State Intellectual Property Office of China Publishes Chengtu Intelligent Tech Shanghai Co Ltd, Shanghai Aerospace Systems Engineering Institute and Shanghai Jiao Tong University P..

Pharmaceutical

| Wed 17 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has published Chengtu Intelligent Tech Shanghai Co Ltd, Shanghai Aerospace Systems Engineering Institute and Shanghai Jiao Tong University patent application for Sequence Recommendation Data Weight Optimization System and Method Based on Reinforcement Learning. The ..

Taiwan Patent Office Publishes Forward Therapeutics Inc Patent Application for Modulators of Tnf-alpha Activity

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has published Forward Therapeutics Inc patent application for Modulators of Tnf-alpha Activity. The invention was developed by Fukase Yoshiyuki and Kanouni Toufike. The patent application number is TW20250112507 20250401. The patent publication number is TW202547476 (A). International P..

Taiwan Patent Office Publishes V6 Therapeutics Inc Patent Application for Selective Jak2 Inhibitors and Uses Thereof

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has published V6 Therapeutics Inc patent application for Selective Jak2 Inhibitors and Uses Thereof. The invention was developed by Athisayamani Jeyaraj Duraiswamy, Gopal Satvik Kotha, Kolli Srinivas, Pandey Anjali, Madica Krishna Prasad and Deshpande Anil Murlidhar. The patent applicat..

State Intellectual Property Office of China Publishes Nanjing Well Pharmaceutical Tech Co Ltd Patent Application for Method for Determining Content of Triethylamine in Vaccine Adju..

Pharmaceutical

| Wed 17 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has published Nanjing Well Pharmaceutical Tech Co Ltd patent application for Method for Determining Content of Triethylamine in Vaccine Adjuvant Mpla and Homologues Thereof. The invention was developed by Wang Ya, Wu Haodi, Zhu Bing, Pan Yuqun, Guo Zhen, Huang Haime..

Taiwan Patent Office Publishes Parallel Bio Patent Application for Methods of Using Immune Organoids to Predict Drug Safety

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has published Parallel Bio patent application for Methods of Using Immune Organoids to Predict Drug Safety. The invention was developed by Hilliard Juliana L and Difazio Robert M. The patent application number is TW20250102165 20250117. The patent publication number is TW202546219 (A). ..

State Intellectual Property Office of China Publishes Canupemmune Therapeutics Inc Patent Application for Ig-like Fusion Proteins for Treatment of Pemphigus Vulgaris and Pemphigus ..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has published Canupemmune Therapeutics Inc patent application for Ig-like Fusion Proteins for Treatment of Pemphigus Vulgaris and Pemphigus Fallen. The invention was developed by Oved Kfir, Denkbel Gerhard, Rief Stephan, Pizul Yosef and Almanzerman Igor. The pate..

State Intellectual Property Office of China Publishes Jiangsu Chia Tai Fenghai Pharmaceutical Co Ltd Patent Application for Compounds for Modulating Microrna-124 Activity

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has published Jiangsu Chia Tai Fenghai Pharmaceutical Co Ltd patent application for Compounds for Modulating Microrna-124 Activity. The invention was developed by Zhu Yongqiang, Jiang Chunhuan, Tang Guqi, Li Chenhui, Wen Tiantian, Dong Zezhang and Shi Jingmiao. T..

State Intellectual Property Office of China Publishes Schuckmann Alfred Von Patent Application for Hand-held Device for Dispensing Portions of Medicament

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has published Schuckmann Alfred Von patent application for Hand-held Device for Dispensing Portions of Medicament. The invention was developed by Von Schuckmann Alfred, Singh Jaskaran, Prasad Subramanian, Bellarirotti Stefano and Vicente Virginia. The patent appl..

State Intellectual Property Office of China Publishes Feierfulai Biological Co Ltd Patent Application for Isoindolinone-glutarimide Antibody Conjugates and Uses Thereof

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has published Feierfulai Biological Co Ltd patent application for Isoindolinone-glutarimide Antibody Conjugates and Uses Thereof. The invention was developed by Arista Luca, Flugare John A, Harvey Frank M, Rickmans Tim, Smith Scott W, Grohmann Christian C and Geiers..

Taiwan Patent Office Publishes Foreseen Technology Beijing Co Ltd and Shanghai Escugen Biotechnology Co Ltd Patent Application for an Antibody Drug Conjugate

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has published Foreseen Technology Beijing Co Ltd and Shanghai Escugen Biotechnology Co Ltd patent application for an Antibody Drug Conjugate. The invention was developed by Zhou Qing, Wong Catherine Chao-lan, Zeng Di, He Feng, Li Wei, Xu Chuan-ying and Han Pei. The patent application nu..

Taiwan Patent Office Publishes Lin Siang Yo Patent Application for a Platform for Targeted Nuclear Delivery of Therapeutic Proteins

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has published Lin Siang Yo patent application for a Platform for Targeted Nuclear Delivery of Therapeutic Proteins. The patent application number is TW20250105600 20250214. The patent publication number is TW202545976 (A). International Patent Classification codes are A61K38/18, A61P35/..

Taiwan Patent Office Publishes Apex Laboratories Private Ltd Patent Application for a Medicinal Composition of Povidone Iodine and a Biopolymer and a Process of Making It

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has published Apex Laboratories Private Ltd patent application for a Medicinal Composition of Povidone Iodine and a Biopolymer and a Process of Making It. The invention was developed by Srinivasan Madhavan, Sulur Vanangamudi Vishagan and Sulur Subramaniam Vanangamudi. The patent applica..

State Intellectual Property Office of China Receives Chengdu Renqing Yishou Pharmaceutical Co Ltd Patent Application for Leaching Device and Method for Preparing Traditional Chines..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has received Chengdu Renqing Yishou Pharmaceutical Co Ltd patent application for Leaching Device and Method for Preparing Traditional Chinese Medicinal Material Wine. He Zhongqing, Zhu Zhi and Xu Liang developed the invention. The patent application number is CN2..

State Intellectual Property Office of China Receives Xinjiang Tianye (Group) and Xinjiang Tianchuang Tech Co Ltd Patent Application for Device and Method for Preparing Nano Calcium..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has received Xinjiang Tianye (Group) and Xinjiang Tianchuang Tech Co Ltd patent application for Device and Method for Preparing Nano Calcium Carbonate PVC Composite Resin. Zhang Weifang, Liu Tianhe, Sun Yujun, Lu Jun, Wan Yage, Zhang Jungui, Zhao Li, Huang Dong, Lyu..

Taiwan Patent Office Receives Averna Therapeutics Ltd Patent Application for Compositions and Methods for Modulating T Cells

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has received Averna Therapeutics Ltd patent application for Compositions and Methods for Modulating T Cells. Ron Maya, Bassan David, Ben Shushan-goleczki Yaron, Alvarez Rodriguez Ruben and Trudeau Devin developed the invention. The patent application number is TW20250116024 20250428. Th..

Taiwan Patent Office Receives Sidewinder Therapeutics Inc Patent Application for Fgfr3-iiib-binding Antibodies

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has received Sidewinder Therapeutics Inc patent application for Fgfr3-iiib-binding Antibodies. Sun Ziyong, Murphy Eric Anthony and Corcoran Ryan Bruce developed the invention. The patent application number is TW20250111898 20250327. The patent publication number is TW202547872 (A). Inte..

Taiwan Patent Office Receives Hoffmann La Roche and Chugai Pharmaceutical Patent Application for Methods of Treating Myasthenia Gravis

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has received Hoffmann La Roche and Chugai Pharmaceutical patent application for Methods of Treating Myasthenia Gravis. Lockey-voyle Nicola Joanne, Ozawa Takatoshi, Klingelschmitt Gaelle Denise Paulette Marie, Zhou Man-di, Yoshida Shunsuke, Ito Hajime and Thanei Gian-andrea Peter developed ..

Taiwan Patent Office Receives Shanghai Aryl Pharmtech Co Ltd and Zhejiang Hisun Pharmaceutical Patent Application for Azatricyclic Derivative and Preparation Method and Use Thereof

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has received Shanghai Aryl Pharmtech Co Ltd and Zhejiang Hisun Pharmaceutical patent application for Azatricyclic Derivative and Preparation Method and Use Thereof. Zhang Pan-pan, Yu Ming Feng, Wang Xin, Zheng Xiao-he, Mao Li-fei, Xu Xiao-jie, Ye Cheng, Cao Qi, Zhou Hou-jiang, Meng Li-chen..

State Intellectual Property Office of China Receives State Power Investment Tech Incubation Co Ltd, Shanghai Nuclear Engineering Research & Design Institute and Shanghai Jiao Tong ..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has received State Power Investment Tech Incubation Co Ltd, Shanghai Nuclear Engineering Research & Design Institute and Shanghai Jiao Tong University patent application for Manufacturing Method of Composite Fuel Rod Cladding and Composite Fuel Rod Cladding. Chen Fu..

State Intellectual Property Office of China Receives Odesai Therapeutics Inc Patent Application for Anti-trailr2 Antigen Binding Proteins and Uses Thereof

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has received Odesai Therapeutics Inc patent application for Anti-trailr2 Antigen Binding Proteins and Uses Thereof. Franche Luigi, Opipari Anthony William, Pinheiro Enrique Maria, Abraham Robert Thomas, Price Lori, Huber Frank, Koenig Pierre-alexander and Dake Todd ..

State Intellectual Property Office of China Receives Jiangsu Hengrui Medicine and Tianjin Hengrui Medicine Co Ltd Patent Application for Fibroblast Activating Protein Ligand and Ap..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has received Jiangsu Hengrui Medicine and Tianjin Hengrui Medicine Co Ltd patent application for Fibroblast Activating Protein Ligand and Application Thereof. Ge Xinyue, Zhou Shunguang, Guo Feihu, Sun Jiyun, Li Zhongqing, Song Zihui and Zhang Mengyi developed the in..

State Intellectual Property Office of China Receives Youshengtai Biomedical Co Ltd Patent Application for Anti-grp78 Antibody and Application Thereof

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has received Youshengtai Biomedical Co Ltd patent application for Anti-grp78 Antibody and Application Thereof. Wu Jiacheng, Cai Yawei, Lin Ziying and Luo Jiaxiang developed the invention. The patent application number is CN20248042426 20240703. The patent publica..

State Intellectual Property Office of China Receives Aibeile Pharmaceutical Tech Co Ltd Patent Application for Compositions and Methods for Determining T Cell Adapter Effects

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has received Aibeile Pharmaceutical Tech Co Ltd patent application for Compositions and Methods for Determining T Cell Adapter Effects. Lu Manqing, Zhou Chuqiao, Lian Yating and Huang Ziren developed the invention. The patent application number is CN20248030180 2..

State Intellectual Property Office of China Receives Lilum Therapeutics Inc Patent Application for Methods for Treating Igf-1r-associated Pediatric Cancers with Insulin-like Growth..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has received Lilum Therapeutics Inc patent application for Methods for Treating Igf-1r-associated Pediatric Cancers with Insulin-like Growth Factor 1 Receptor Ligands Conjugated to Cytotoxic Agents. Hobman Matthew developed the invention. The patent application n..

State Intellectual Property Office of China Receives Sam A Pharm Co Ltd Patent Application for Preparation Method of Pharmaceutical Composition Containing Pranlukast and Pharmaceut..

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has received Sam A Pharm Co Ltd patent application for Preparation Method of Pharmaceutical Composition Containing Pranlukast and Pharmaceutical Composition Prepared by Preparation Method. Lu Xianzong, Kim Kyung-hee and Kil Young-sik developed the invention. The ..

Taiwan Patent Office Receives Sema4 Opco Inc, Icahn School Med Mount Sinai and Sanofi US Services Inc Patent Application for Biomarkers That Predict Clinical Response or Remission ..

Pharmaceutical

| Thu 18 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has received Sema4 Opco Inc, Icahn School Med Mount Sinai and Sanofi US Services Inc patent application for Biomarkers That Predict Clinical Response or Remission in Asthma Patients. Habiel David, Zhang Lu, Lee Eun-jee, Rogers Linda, Hao Ke, Schadt Eric E and Zhu Jun developed the inventio..

Taiwan Patent Office Receives Qilu Animal Health Products Co and Qilu Pharmaceutical Patent Application for Isoxazoline Compound and Use Thereof

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has received Qilu Animal Health Products Co and Qilu Pharmaceutical patent application for Isoxazoline Compound and Use Thereof. Zheng Huan-qing, Fang Ming-feng, Ma Qing-zhu, Liu Quan-cai, Zhou Shi-yu, Fan Chuan-wen and Kong Mei developed the invention. The patent application number is ..

Taiwan Patent Office Receives University Houston System and Tract Pharmaceuticals Inc Patent Application for Compounds and Compositions Useful for Treatment of Proliferative Diseas..

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has received University Houston System and Tract Pharmaceuticals Inc patent application for Compounds and Compositions Useful for Treatment of Proliferative Disease or Disorder. Mckeon Frank, Vincent Matthew, Xian Wa and Russell Richard E developed the invention. The patent application ..

State Intellectual Property Office of China Receives Beijing University, Beijing Hotgen Biotechnology Co Ltd and Ningbo Medical Treatment Center Lihuili Hospital Ningbo University ..

Pharmaceutical

| Wed 17 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has received Beijing University, Beijing Hotgen Biotechnology Co Ltd and Ningbo Medical Treatment Center Lihuili Hospital Ningbo University Lihuili Hospital patent application for Biomarker for Non-invasive Diagnosis of Chronic Hepatitis B Liver Injury, Diagnosis Mo..

State Intellectual Property Office of China Receives Harbin Pharmaceutical Group Sanjing Pharmaceutical Holdings Co Ltd Patent Application for Method for Detecting Vitamin K2 in So..

Pharmaceutical

| Wed 17 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has received Harbin Pharmaceutical Group Sanjing Pharmaceutical Holdings Co Ltd patent application for Method for Detecting Vitamin K2 in Soft Capsule. Liu Yang, Jin Xuna, Yao Huimin, Xie Yingxin, Wang Xinguo, Yan Mei, Bai Yang, Fan Ning, Zhu Yuchen and Xia Linlin d..

State Intellectual Property Office of China Receives Shandong Jinzhang Longxiang Intelligent Tech Co Ltd Patent Application for Traditional Chinese Medicine Decoction Piece Roastin..

Pharmaceutical

| Wed 17 Jun 2026

Beijing, June 18 -- State Intellectual Property Office of China has received Shandong Jinzhang Longxiang Intelligent Tech Co Ltd patent application for Traditional Chinese Medicine Decoction Piece Roasting End Point On-line Intelligent Near-infrared Detection Device Suitable for High-temperature Environment and Method Thereof. Z..

Taiwan Patent Office Receives Futuregen Biopharmaceutical Beijing Co Ltd Patent Application for Antibodies Capable of Specifically Binding Tl1a and Use Thereof

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has received Futuregen Biopharmaceutical Beijing Co Ltd patent application for Antibodies Capable of Specifically Binding Tl1a and Use Thereof. Zhang Li-na, Huo Nai-fan, Li Yun, Jin Zhao-yu, Yang Ya-ping, Li Feng, Zhao An, Li Yue and Cao An developed the invention. The patent applicatio..

Taiwan Patent Office Receives Mello Biotech Taiwan Co Ltd, Sam Lin and Lin Shi Lung Patent Application for Novel Induced Cytoplasmic IVT (ICIVT)-like Composition and the Related Va..

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has received Mello Biotech Taiwan Co Ltd, Sam Lin and Lin Shi Lung patent application for Novel Induced Cytoplasmic IVT (ICIVT)-like Composition and the Related Vaccine Medicine Designs Thereof. Lin Shi-lung, Wu Yu-jing, Sam Lin, Hung Wei-chih and Liu Hsien-lin developed the invention. ..

Taiwan Patent Office Receives Jiangsu Yahong Meditech Co Ltd and Asieris Pharmaceuticals, Shanghai Patent Application for Usp1 Inhibitors and Medical Uses Thereof

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Taiwan Patent Office has received Jiangsu Yahong Meditech Co Ltd and Asieris Pharmaceuticals, Shanghai patent application for Usp1 Inhibitors and Medical Uses Thereof. Huang Qi, Chen Yun-fei, Jin Hong-yue, Chen Yu, Sun Qiao-ling and Song Xia developed the invention. The patent application number is TW202501..

Anivance Ai Corp Seeks Patent for System for Mimicking Cellular Microenvironment and Method for Evaluating Cell Development or Drug Therapy Effectiveness Using the Same

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Anivance Ai Corp has sought patent for System for Mimicking Cellular Microenvironment and Method for Evaluating Cell Development or Drug Therapy Effectiveness Using the Same. This invention was developed by Chen Guan-yu, Huang Chien-yu and Lin Yu-chien. The patent application number is TW20240120351 2024053..

Chengdu Gowell Bio Pharmaceutical Co Ltd Seeks Patent for an Sirna, SiRNA Conjugate, Pharmaceutical Composition, Kit and Use Thereof

Pharmaceutical

| Thu 18 Jun 2026

Taipei, June 18 -- Chengdu Gowell Bio Pharmaceutical Co Ltd has sought patent for an Sirna, SiRNA Conjugate, Pharmaceutical Composition, Kit and Use Thereof. This invention was developed by Chen You-jin, Wu Yue-qi, Wei Chuan-lai, Huang Yi, Zhou Wei and Lv Fei-long. The patent application number is TW20250116345 20250430. The ..

Hangzhou Baicreat Pharma Tech Co Ltd Seeks Patent for Oxamide Compounds and Pharmaceutical Use Thereof

Pharmaceutical

| Thu 18 Jun 2026

Taipei, June 18 -- Hangzhou Baicreat Pharma Tech Co Ltd has sought patent for Oxamide Compounds and Pharmaceutical Use Thereof. This invention was developed by Zhang Feng-min and Lei Chong. The patent application number is TW20250116342 20250430. The patent publication number is TW202543652 (A). International Patent Classific..

Genfleet Therapeutics Shanghai Inc Seeks Patent for Anti-gdf-15 Antibody and Use Thereof

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Genfleet Therapeutics Shanghai Inc has sought patent for Anti-gdf-15 Antibody and Use Thereof. This invention was developed by Zhu Seng, Zhou Fu-sheng, Lan Jiong, Li Yu-mei, Lu Qiang, Jin Lei and He Xiang-yu. The patent application number is TW20250115391 20250423. The patent publication number is TW2025478..

Nippon Chemiphar Co Seeks Patent for Pharmaceutical Composition for Treating Chronic Kidney Diseases Whose Urine Albumin Concentration Before Treatment is in a Specific Range

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Nippon Chemiphar Co has sought patent for Pharmaceutical Composition for Treating Chronic Kidney Diseases Whose Urine Albumin Concentration Before Treatment is in a Specific Range. This invention was developed by Yamasaki Satomi and Nakai Toshiki. The patent application number is TW20250111525 20250326. The..

Maha Therapeutics Inc Seeks Patent for Cleavable Ester Compounds and Uses Thereof

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Maha Therapeutics Inc has sought patent for Cleavable Ester Compounds and Uses Thereof. This invention was developed by Alhamadsheh Mamoun. The patent application number is TW20250112218 20250328. The patent publication number is TW202547452 (A). International Patent Classification codes are A61K31/075, A61..

Shaanxi Iok Pharmaceutical Co Ltd Seeks Patent for Method for Synchronously and Quantitatively Detecting 14 Components in Fructus Forsythiae Based on Ultra-high Performance Liquid ..

Pharmaceutical

| Wed 17 Jun 2026

Beijing, June 18 -- Shaanxi Iok Pharmaceutical Co Ltd has sought patent for Method for Synchronously and Quantitatively Detecting 14 Components in Fructus Forsythiae Based on Ultra-high Performance Liquid Chromatography. This invention was developed by Song Wei, Gao Ke, Xie Xiaofeng and Bao Lizhi. The patent application numbe..

Green Carbon Forever Technology Co Ltd Seeks Patent for Process Liquid Treatment System Based on Heavy Calcium Carbonate

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Green Carbon Forever Technology Co Ltd has sought patent for Process Liquid Treatment System Based on Heavy Calcium Carbonate. This invention was developed by Chang Hong-yi, Tseng Yao-hsuan, Liu Chien-liang, Lo Chin-chung and Chang Hong -yi. The patent application number is TW20240118507 20240520. The paten..

Merdury Biopharmaceutical Corp Seeks Patent for Structure of Oral Peptide Drug and Production Method Thereof Mainly Including a Lozenge and a Coating Layer Coated on an Outer Layer..

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Merdury Biopharmaceutical Corp has sought patent for Structure of Oral Peptide Drug and Production Method Thereof Mainly Including a Lozenge and a Coating Layer Coated on an Outer Layer of the Lozenge. This invention was developed by Chen Zhao-yi and Lin Xian-de. The patent application number is TW202401181..

Usai Co Ltd Applies for Patent on Medicine Cabinet System and Dispensing Device Capable of Automatically Delivering the Medicine Out of the Dispensing Device Thereby Facilitating S..

Pharmaceutical

| Thu 18 Jun 2026

Taipei, June 18 -- Usai Co Ltd has applied Taiwan patent for Medicine Cabinet System and Dispensing Device Capable of Automatically Delivering the Medicine Out of the Dispensing Device Thereby Facilitating Subsequent Packaging and Reducing Reliance on Manual Labor for Medicine Retrieval Operation. Hsu Chia-ming and Hsu Chih-wei ..

Ativa Biomedical Corp Applies for Patent on Treatment of Autoimmune Disorders with Nk Cells

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Ativa Biomedical Corp has applied Chinese patent for Treatment of Autoimmune Disorders with Nk Cells. Flynn Patrick, Graef Thomas, Arslan Fatih, Raymond Heather K, Guerrettaz Ludovic, Rogers Peter and Viomet Nathalie developed it. The patent application number is CN20248046954 20240514. The patent publicat..

Frontier Pharmaceuticals Inc Applies for Patent on Pyrido [4, 3-d] Pyrimidine Derivatives as Mutant KRAS G12C Inhibitors for Treatment of Cancer

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Frontier Pharmaceuticals Inc has applied Chinese patent for Pyrido [4, 3-d] Pyrimidine Derivatives as Mutant KRAS G12C Inhibitors for Treatment of Cancer. Gerken Peter A, Patel Sachin, Wilhelm Matthew J, Sarkino Robert R and Dransfield Paul John developed it. The patent application number is CN20248042550 ..

Jinghua Pharmaceutical Group Nantong Co Ltd Applies for Patent on Drug Intermediate Separation Device and Method Thereof

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Jinghua Pharmaceutical Group Nantong Co Ltd has applied Chinese patent for Drug Intermediate Separation Device and Method Thereof. Fan Zhiqiang, Zhou Shixin and Gao Liyan developed it. The patent application number is CN202511723292 20251121. The patent publication number is CN121623716 (A). International ..

Guangzhou Communications Group Logistics Co Ltd Applies for Patent on Intelligent Risk Control Management Method for Medicine Supply Chain

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Guangzhou Communications Group Logistics Co Ltd has applied Chinese patent for Intelligent Risk Control Management Method for Medicine Supply Chain. Wang Sen, Su Jieying, Tan Yisheng, Ying Qi, Gu Yubo, Yan Sihan and Da Lai developed it. The patent application number is CN202511994392 20251226. The patent p..

Ping An Shionogi Co Ltd Applies for Patent on Drug Resistance Prediction Method, Drug Resistance Prediction Apparatus, Electronic Device, and Storage Medium

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Ping An Shionogi Co Ltd has applied Taiwan patent for Drug Resistance Prediction Method, Drug Resistance Prediction Apparatus, Electronic Device, and Storage Medium. Yamakawa Hidekuni, Yin Li-ni and Kodaira Naoki developed it. The patent application number is TW20250115152 20250422. The patent publication n..

Emwicon Corp Applies for Patent on Smart Medicine Capsule

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Emwicon Corp has applied Taiwan patent for Smart Medicine Capsule. Lin Chin-lung developed it. The patent application number is TW20240120704 20240604. The patent publication number is TW202547419 (A). International Patent Classification codes are A61B5/07, A61J3/07 and A61K9/48. The abstract of the pat..

Sklbio Biopharmaceuticals Corp Applies for Patent on Cyproheptadine Derivatives

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Sklbio Biopharmaceuticals Corp has applied Taiwan patent for Cyproheptadine Derivatives. Chan Wing-yan Michael, Wu Jin-yi, Shen Cheng-huang, Lee Ming-yang, Liu Yi-wen, Shen Cheng Huang and Chan Wing Yan Michael developed it. The patent application number is TW20240126838 20240718. The patent publication num..

Beijing Puqi Pharmaceutical Tech Co Ltd Applies for Patent on Antagonists of Mas-related G Protein Receptor X2 and Uses Thereof

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Beijing Puqi Pharmaceutical Tech Co Ltd has applied Chinese patent for Antagonists of Mas-related G Protein Receptor X2 and Uses Thereof. Yang Yanqing, Zhu Li, Hu Wei, Dai Liguang, Zhang Hui, Zhu Bing and Du Yunlong developed it. The patent application number is CN20248044601 20240712. The patent publicati..

Beijing Puqi Pharmaceutical Tech Co Ltd Applies for Patent on Mrgprx2 Antagonist, Pharmaceutical Composition and Application Thereof

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Beijing Puqi Pharmaceutical Tech Co Ltd has applied Chinese patent for Mrgprx2 Antagonist, Pharmaceutical Composition and Application Thereof. Yang Yanqing, Zhu Li, Dai Liguang, Hu Wei, Zhang Hui, Zhu Bing and Du Yunlong developed it. The patent application number is CN20248043350 20240628. The patent publ..

Hangzhou Jiechuangrui Medical Tech Co Ltd Applies for Patent on Websocket Connection Management Method of Shock Wave Therapeutic Apparatus

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Hangzhou Jiechuangrui Medical Tech Co Ltd has applied Chinese patent for Websocket Connection Management Method of Shock Wave Therapeutic Apparatus. He Chuan, Lyu Shu'an, Liu Di and Feng Boqi developed it. The patent application number is CN202511691893 20251118. The patent publication number is CN12153102..

Ji Yan Biomedical Co Ltd Applies for Patent on Immunoconjugate, Pharmaceutical Composition Comprising the Same, and Uses Thereof in Treating Cancers

Pharmaceutical

| Thu 18 Jun 2026

Taipei, June 18 -- Ji Yan Biomedical Co Ltd has applied Taiwan patent for Immunoconjugate, Pharmaceutical Composition Comprising the Same, and Uses Thereof in Treating Cancers. Wang Hwei-jiung, Cheng Tsai-mu, Lee Cheng-chung, Wu Ming-heng, Shen Hsieh-tsung and Zhang Bo-xiang developed it. The patent application number is TW20..

Guangzhou Runlin Pharmaceutical Technology Co Ltd, Guangzhou Unirise Pharmaceutical Co Ltd, Guangzhou Apichope Pharmaceutical Co Ltd and Apichope Bio Pharmaceutical Co Ltd Applies ..

Pharmaceutical

| Thu 18 Jun 2026

Taipei, June 18 -- Guangzhou Runlin Pharmaceutical Technology Co Ltd, Guangzhou Unirise Pharmaceutical Co Ltd, Guangzhou Apichope Pharmaceutical Co Ltd and Apichope Bio Pharmaceutical Co Ltd has applied Taiwan patent for Compound as Xanthine Oxidase Inhibitor and the Application Thereof. Liu Jianzhong, Wang Hui, Hu Bo-yu, Li Han..

Laekna Pharmaceutical Ningbo Co Ltd Files Taiwan Patent Application for Heteroaryl Compounds and Their Use as Pi3k Alpha Inhibitors

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Laekna Pharmaceutical Ningbo Co Ltd has filed a patent application for Heteroaryl Compounds and Their Use as Pi3k Alpha Inhibitors. This invention was developed by Gu Xiang-ju Justin, Li Ming, Zhang Rui-peng, Hu Mei-juan and Chen Chun-yen. The patent application number is TW20250120341 20250529. The patent ..

Shaanxi Kanghui Pharmaceutical Co Ltd Files Chinese Patent Application for Method for Detecting Content of Effective Components in Seven-ingredient Gastrodia Elata Medicinal Liquor

Pharmaceutical

| Wed 17 Jun 2026

Beijing, June 18 -- Shaanxi Kanghui Pharmaceutical Co Ltd has filed a patent application for Method for Detecting Content of Effective Components in Seven-ingredient Gastrodia Elata Medicinal Liquor. This invention was developed by Gong Zheng, Fu Pei, Wang Chunmei, Chen Shizhong, Liu Yao and Zhang Shijun. The patent applicati..

Shanghai Milestone Pharmaceutical Tech Co Ltd Files Chinese Patent Application for ICP-OES (inductively Coupled Plasma-optical Emission Spectrometer) Detection Method for Carbomer ..

Pharmaceutical

| Wed 17 Jun 2026

Beijing, June 18 -- Shanghai Milestone Pharmaceutical Tech Co Ltd has filed a patent application for ICP-OES (inductively Coupled Plasma-optical Emission Spectrometer) Detection Method for Carbomer Content in Cyclosporine Eye Drops. This invention was developed by Gu Kai, Chen Bing, Zhu Zifeng, Zhao Feiyang, Zhang Chuhang, Xiang..

Green Carbon Forever Technology Co Ltd Files Taiwan Patent Application for Process Liquid Treatment System Based on Biomass Calcium Carbonate

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- Green Carbon Forever Technology Co Ltd has filed a patent application for Process Liquid Treatment System Based on Biomass Calcium Carbonate. This invention was developed by Chang Hong-yi, Tseng Yao-hsuan, Liu Chien-liang, Lo Chin-chung and Chang Hong -yi. The patent application number is TW20240118501 2024..

En Otsuka Pharmaceutical Co Files Taiwan Patent Application for Composition

Pharmaceutical

| Wed 17 Jun 2026

Taipei, June 18 -- En Otsuka Pharmaceutical Co has filed a patent application for Composition. This invention was developed by Sasaki Yuya. The patent application number is TW20250103653 20250124. The patent publication number is TW202545552 (A). International Patent Classification codes are A23L33/105, A61K36/31 and A61P1/16..

Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd Files Chinese Patent Application for Arylamine Compound with Protein Degradation Effect

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd has filed a patent application for Arylamine Compound with Protein Degradation Effect. This invention was developed by Zhang Zhimin, Chen Min, Chang Yujie, Zheng Yongyong, Zhai Wenqiang and Liu Dongzhou. The patent application number is CN20248045028 20240726..

Laikai Pharmaceutical Ningbo Co Ltd Files Chinese Patent Application for Pyrimidine Compounds and Their Use as Usp1 Inhibitors

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Laikai Pharmaceutical Ningbo Co Ltd has filed a patent application for Pyrimidine Compounds and Their Use as Usp1 Inhibitors. This invention was developed by Wang Jintao, Li Ming, Chen Yan, Chen Junyan and Gu Xiangju. The patent application number is CN20248047062 20240208. The patent publication number is..

Simcere Remediation Pharmaceutical Co Ltd Files Chinese Patent Application for Use of Compound for Preventing or Treating 53bp1/shieldin Complex Deficient Cancer

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Simcere Remediation Pharmaceutical Co Ltd has filed a patent application for Use of Compound for Preventing or Treating 53bp1/shieldin Complex Deficient Cancer. This invention was developed by Zhou Feng, Jiang Lei, Liu Lu, Qian Shuo, Li Zhengtao, Li Zhen, Li Jian and Tang Renhong. The patent application nu..

Nvida Therapeutics Inc Files Chinese Patent Application for Isoandrographolide Analogs and Methods of Treatment Thereof

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Nvida Therapeutics Inc has filed a patent application for Isoandrographolide Analogs and Methods of Treatment Thereof. This invention was developed by Gottumukkala Subbaraju Venkata, Cherukupalli Kiran, Norman Brian Hurst, Jadhav Prabhakar K, Karasanasis Sotirios K, Mandal Goutham and Mukhopadhyay Indranil. ..

Gento Pharmaceutical Co Ltd Files Chinese Patent Application for Pharmaceutical Composition Comprising Crisdesalazine with Improved Stability and Dissolution Rate

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Gento Pharmaceutical Co Ltd has filed a patent application for Pharmaceutical Composition Comprising Crisdesalazine with Improved Stability and Dissolution Rate. This invention was developed by Gwag Byoung-joo, Cho Sung-ik, Azam Sherif Mohamed Shafiul, Kim Gyeong-ok, An Chunshan, Park Young-joon, Cui Shu and ..

Kadmon Corporation LLC Files Taiwan Patent Application for Methods of Treating Chronic Graft Versus Host Disease with Belumosudil After Ceasing Administration of Ruxolitinib

Pharmaceutical

| Thu 18 Jun 2026

Taipei, June 18 -- Kadmon Corporation LLC has filed a patent application for Methods of Treating Chronic Graft Versus Host Disease with Belumosudil After Ceasing Administration of Ruxolitinib. This invention was developed by Skaar Jeffrey, Taitel Haya and Sapra Rajat. The patent application number is TW20250107064 20250226. T..

Guangdong Yangble Biopharmaceuticals Co Ltd Submits Patent Application for Vertical Mixing Equipment for Producing Compound Amoxicillin Powder

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Guangdong Yangble Biopharmaceuticals Co Ltd has submitted a patent application for Vertical Mixing Equipment for Producing Compound Amoxicillin Powder. Yang Shaolin, Liang Hengfeng, Li Jin and Ma Ke developed the invention. The patent application number is CN202511855281 20251210. The patent publication nu..

Xinli Beijing Pharmaceutical Tech Co Ltd Submits Chinese Patent Application for Multi-leaf Grating Device with Compact Motor Arrangement

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Xinli Beijing Pharmaceutical Tech Co Ltd has submitted a patent application for Multi-leaf Grating Device with Compact Motor Arrangement. This invention was developed by Chen Liang. The patent application number is CN202511815267 20251204. The patent publication number is CN121623178 (A). International Pat..

Ningxia Tianxin Pharmaceutical Co Ltd Submits Chinese Patent Application for Catalyst, and Preparation Method and Application of Composite Catalyst

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Ningxia Tianxin Pharmaceutical Co Ltd has submitted a patent application for Catalyst, and Preparation Method and Application of Composite Catalyst. This invention was developed by Chen Yixiang, Shang Zhou, Zhao Liming, Feng Zhengchuan and Lyu Lei. The patent application number is CN202411654929 20241119. ..

Jinan Tianju Animal Husbandry Tech Co Ltd Submits Chinese Patent Application for Ddx5 Protein-targeted Anti-fowl Adenovirus Veterinary Drug Composition and Application Thereof

Pharmaceutical

| Thu 18 Jun 2026

Beijing, June 18 -- Jinan Tianju Animal Husbandry Tech Co Ltd has submitted a patent application for Ddx5 Protein-targeted Anti-fowl Adenovirus Veterinary Drug Composition and Application Thereof. This invention was developed by Zhang Haijun, Liu Hailiang and Gao Yugang. The patent application number is CN202610148712 2026020..

1 to 100 of 1944 Items Next >>

Home
|
About Us
|
Privacy Policy
|
Support
|
Products
|
Careers
|
Contact Us

© Copyright 2015. All Right Reserved.

Email selected articles